Association of Molecular Subtypes with Pathologic Response, PFS and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
Seth P LernerDavid J McConkeyCatherine M TangenJoshua J MeeksThomas W FlaigXing HuaSiamak DaneshmandAjjai Shivaram AlvaM Scott LuciaDan TheodorescuAmir GoldkornMatthew I MilowskyW ChoiRick BangsDaniel L GustafsonMelissa PletsIan M ThompsonPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
The Consensus classifier, based in part on the TCGA and MDA classifiers, modestly improved prediction for pathologic downstaging but subtypes were not associated with PFS or OS.